Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 175,000 --
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 200,652 --
Jan 15, 2018
Director
Director Bona fide gift 1,431 --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Bona fide gift 20,000 --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Bona fide gift 774 --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 175,000 --
Jan 15, 2018
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 38,889 --
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 412,500 --
Jan 09, 2018
Director
Director Other acquisition or disposition -- --
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 985,444 --
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 650,000 $9.18
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 955,847 $11.34
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 500,000 $3.92
Jan 09, 2018
Director
Director Other acquisition or disposition -- --
Jan 09, 2018
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,500,294 $18.03
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 500,000 --
Jan 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 622,376 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.